Latest Breaking News On - Seanr smith - Page 1 : comparemela.com

ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co , Inc , Rahway,

- Evaluation of IOS-1002, a LILRB1 (ILT2), LILRB2 (ILT4), KIR3DL1 targeting agent, in combination with KEYTRUDA® (pembrolizumab) as part of ongoing Phase 1a/b trial in advanced solid tumors

United statesSchroder adveqSeanr smithChristoph rennerLudger wess ines regina buthMerck co incMission biocapitalMerck sharp dohmeZurich areaImmunos therapeuticsChief medical officerChief executive officerMerck sharpSamsara biocapitalLightspeed venture partnersPfizer ventures

ImmunOs Therapeutics Announces Appointment of Joseph Leveque, MD, to its Board of Directors

ImmunOs Therapeutics Announces Appointment of Joseph Leveque, MD, to its Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Santa clara universityUnited statesWharton schoolUniversity of texasLudger wess ines regina buthJoseph levequeSeanr smithEli lillyJoe levequeBristol myers squibbLos angelesSchroder adveqUniversity of californiaSinai medical centerMission biocapitalCompany contactimmunos therapeutics ag wagistrasse

ImmunOs Therapeutics Announces Appointment of Joseph

- Seasoned immuno-oncology executive brings significant medical and biopharma expertise Schlieren (Zurich Area), Switzerland, and Gaithersburg, MD,.

Santa clara universityUnited statesWharton schoolUniversity of texasLudger wess ines regina buthJoseph levequeSeanr smithEli lillyJoe levequeBristol myers squibbLos angelesSchroder adveqUniversity of californiaSinai medical centerCompany contactMission biocapital

ImmunOs Therapeutics Raises $74 Million Series B Financing Round

ImmunOs Therapeutics Raises $74 Million Series B Financing Round
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDaniel vasellaShelley chuReinhard ambrosLudger wess ines regina buthMarcos millaMarkus hosangSeanr smithMichael baranAndreas jurgeitSchroder adveqHead of the novartis venture fundCompany board of directorsCompany contactMission biocapitalZurich area

ImmunOs Therapeutics Raises $74M in Series B Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Daniel vasellaShelley chuReinhard ambrosMarkus hosangMarcos millaSeanr smithMichael baranAndreas jurgeitSchroder adveqHead of the novartis venture fundMission biocapitalImmunos therapeuticsZurich areaSamsara biocapitalLightspeed venture partnersFiscus financial